MDT

86.64

+1.07%↑

113.82

+1.66%↑

VEEV

175.34

+0.03%↑

HQY

83.66

+3.08%↑

CSBR

5.7

+2.52%↑

MDT

86.64

+1.07%↑

113.82

+1.66%↑

VEEV

175.34

+0.03%↑

HQY

83.66

+3.08%↑

CSBR

5.7

+2.52%↑

MDT

86.64

+1.07%↑

113.82

+1.66%↑

VEEV

175.34

+0.03%↑

HQY

83.66

+3.08%↑

CSBR

5.7

+2.52%↑

MDT

86.64

+1.07%↑

113.82

+1.66%↑

VEEV

175.34

+0.03%↑

HQY

83.66

+3.08%↑

CSBR

5.7

+2.52%↑

MDT

86.64

+1.07%↑

113.82

+1.66%↑

VEEV

175.34

+0.03%↑

HQY

83.66

+3.08%↑

CSBR

5.7

+2.52%↑

Strona główna・Stock List・Progyny Inc

Progyny Inc

Open

SectorHealthcare

17 -0.58

Buy Sell

Overview

Share price change

24h

Current

Min

16.57

Max

17.19

Key metrics
By Trading Economics
Income	-1.4M 12M
Sales	5.1M 318M
P/E Sector Avg	27.708 57.05
Profit margin	3.921
Employees	835
EBITDA	-6M 19M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+57.61% upside

Dividends
By Dow Jones
Next Earnings	7 maj 2026

Market Stats
By TradingEconomics
Market Cap	-362M 1.5B
Previous open	17.58
Previous close	17

News Sentiment

By Acuity

20%

80%

46 / 349 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

22.91 / 23.375 Support & Resistance

Progyny Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

30 mar 2026, 23:15 UTC

Major News Events

U.K. Shoppers Paid a Little More This Month But Worse May yet Lie Ahead

30 mar 2026, 22:36 UTC

Major News Events

Australian Government Rules Out Boots on the Ground in the Middle East

30 mar 2026, 22:13 UTC

Acquisitions, Mergers, Takeovers

Sun Life Financial Agrees to Buy Bell Partners for $350 Million

30 mar 2026, 21:00 UTC

Earnings

Aktis Oncology Gets FDA Clearance for Phase 1 Billion Trial of Tumor Treatment

30 mar 2026, 20:15 UTC

Major News Events

Fed's Williams: Middle-East Developments Have Added Significant Economic Uncertainty

30 mar 2026, 23:40 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

30 mar 2026, 23:40 UTC

Market Talk

Nikkei May Decline on Higher Energy Cost Concerns -- Market Talk

30 mar 2026, 23:36 UTC

Market Talk

Gold Edges Lower Amid Divergent Signals on U.S.-Iran Talks -- Market Talk

30 mar 2026, 23:12 UTC

Market Talk

Alcoa Earnings Outlook Boosted by Market Disruptions -- Market Talk

30 mar 2026, 22:49 UTC

Market Talk

Fed's Williams: Core Inflation Forecast Is Little Changed -- Market Talk

30 mar 2026, 22:44 UTC

Market Talk

Fed's Williams: Risks to Both Sides of Dual Mandate Higher -- Market Talk

30 mar 2026, 22:43 UTC

Market Talk

Fed's Williams Says Focus Is on Inflation Expectations Being Well Anchored -- Market Talk

30 mar 2026, 22:42 UTC

Market Talk

South32 Should Go for Growth, Says New Bull -- Market Talk

30 mar 2026, 22:18 UTC

Market Talk

Paragon Care's Chances of Using Levy to Pass on Higher Costs `Close to Zero' -- Market Talk

30 mar 2026, 22:05 UTC

Market Talk

Northern Star's New Bull Argues Case for Asset Sales -- Market Talk

30 mar 2026, 21:58 UTC

Acquisitions, Mergers, Takeovers

Sun Life Financial Agrees to Buy Bell Partners for $350M

30 mar 2026, 21:39 UTC

Acquisitions, Mergers, Takeovers

Sun Life Sees 1Q Charge to Net of C$236M From BGO, Crescent Deals

30 mar 2026, 21:38 UTC

Acquisitions, Mergers, Takeovers

Sun Life: Completes Remaining Equity Interest Purchases of BGO, Crescent Capital

30 mar 2026, 21:36 UTC

Acquisitions, Mergers, Takeovers

Sun Life to Buy Fully Bell Partners for $350M >SLF.T

30 mar 2026, 21:33 UTC

Acquisitions, Mergers, Takeovers

Unilever Shareholders Expected to Own Two-Thirds of New Food Entity, Sources Say -- WSJ

30 mar 2026, 21:33 UTC

Acquisitions, Mergers, Takeovers

Unilever Nears Deal to Create $60 Billion Food Giant With McCormick -- WSJ

30 mar 2026, 21:33 UTC

Acquisitions, Mergers, Takeovers

Deal Could Be Announced As Soon As Tuesday, Sources Say -- WSJ

30 mar 2026, 21:33 UTC

Acquisitions, Mergers, Takeovers

Unilever Nears Cash-and-Stock Deal to Combine Food Business With McCormick, Sources Say -- WSJ

30 mar 2026, 21:33 UTC

Acquisitions, Mergers, Takeovers

Deal Set to Value Combined Food Business At Around $60B Including Debt, Sources Say -- WSJ

30 mar 2026, 21:25 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

30 mar 2026, 21:25 UTC

Market Talk

Warehouse Showing Cost Discipline But Margin Goal at Risk -- Market Talk

30 mar 2026, 21:03 UTC

Acquisitions, Mergers, Takeovers

Sun Life: Completes Equity Interest Purchases of BGO and Crescent Cap, Announces Acquisition of Bell Partners, a Multifamily Real Estate Investment Manager

30 mar 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

30 mar 2026, 20:09 UTC

Earnings

This Stock Looks Like a Solid AI Bet -- and Wall Street Hasn't Noticed Yet -- Barrons.com

30 mar 2026, 20:00 UTC

Major News Events

Fed's Williams: Middle-East Conflict 'Will Likely Boost Overall Inflation in Coming Months'

Peer Comparison

Price change

Progyny Inc Forecast

Price Target

By TipRanks

57.61% upside

12 Months Forecast

Average 27.22 USD 57.61%

High 31 USD

Low 19 USD

Based on 9 Wall Street analysts offering 12 month price targets forProgyny Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

9 ratings

Buy

Hold

Sell

Based on 9 analysts giving stock ratings to Progyny Inc - Dist in the past 3 months.

Technical Score

By Trading Central

22.91 / 23.375Support & Resistance

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

Sentiment

By Acuity

46 / 349 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Progyny Inc

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.